Items tagged with Treatment
Levofloxacin: safety and tolerability in HIV positive and negative children treated for MDR-TB (post)
Levofloxacin was safe and well tolerated in children with and without HIV in long-term use. The data provide additional support for its inclusion in paediatric TB treatment and prevention regimens. [1]
Shortened nine-month MDR-TB regimen works well in children and adolescents (post)
The nine-month Bangladesh regimen for treatment of multidrug-resistant tuberculosis (MDR-TB) was successful in 83% of children and adolescents in an observational trial conducted in francophone Africa, presented at TB2016. [1]
Universal treatment of multidrug-resistant TB is possible within current budgets with generic production (post)
Generic production could make novel multidrug-resistant tuberculosis (MDR-TB) regimens available for US $53–507 per treatment course according to data presented at TB2016.
Global Drug Facility 2016 Catalogue (post)
The Stop TB Partnership's Global Drug Facility (GDF) has published its 2016 Catalogue. The catalogue details prices and descriptions of products that can be ordered through GDF. Countries and programmes that enable health care providers to treat patients according to the latest WHO treatment guidelines can procure quality-assured products through GDF.
Multidrug-resistant TB treatment in North Korea: is scale-up possible? (post)
Summary points
New TB drug for children introduced in Papua New Guinea (post)
A new tuberculosis (TB) drug for children was launched today (August 9) by the PNG Paediatric Society, in partnership with World Health Organisation, National Department of Health, NCD Health, Port Moresby General Hospital (PMGH) and Exxon Mobil.
First govt-funded bedaquiline treatment for TB initiated in Mumbai (post)
The beginning of bedaquiline medication will be a boost in the fight against the bacterial infection which has caused a rising incidence of multidrug-resistant (MDR-) and extensively drug-resistant (XDR-)TB cases in Mumbai.
Eugene Bell Foundation calls for support to treat more TB patients in North Korea (post)
SEOUL, Aug. 17 -- The head of the Eugene Bell Foundation Korea on Wednesday voiced hope that more tuberculosis patients in North Korea could receive timely medication even at a time of heightened inter-Korean tensions.
Bangladesh introducing cheaper, shorter MDR-TB treatment course in January (post)
Bangladesh is changing the way the world treats the dangerous form of tuberculosis as the country’s own research has received World Health Organisation’s (WHO) approval.
Simulated patient study sheds new light on antibiotic use in India (post)
As a result of the overuse or misuse of antibiotics, antimicrobial resistant superbugs represent an extraordinary threat to global health. This threat is particularly great in India, the world’s largest consumer of antibiotics and the country facing the highest burden of tuberculosis (TB) in the world.
Page 23 of 108 · Total posts: 0
←First 22 23 24 Last→